ArticleJournal of clinical oncology : official journal of the American Society of Clinical Oncology2009

Are HER2 and TOP2A useful as prognostic or predictive biomarkers for anthracycline-based adjuvant chemotherapy for breast cancer?

Kathleen I PritchardPubMed ↗Publisher ↗

No numbers read from the abstract.